|
|
|||||||
Acute Lymphoblastic Leukemia |
* Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany;
° Department of Epidemiology, Social Medicine and Heatlh System Research, Hannover Medical School, Hannover, Germany;
# Department of Pediatric Pulmonology and Neonatology, Hannover Medical School, Hannover, Germany;
@ Department of Pediatrics; City Hospital; Oldenburg, Germany;
^ University Childrens Hospital, Kiel, Germany
Correspondence: Martin Stanulla, M.D., M.Sc., Department of Pediatric Hematology and Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Phone: international +49.511.532 6712. Fax: international +49.5115329029. E-mail: stanulla.martin{at}mh-hannover.de
In a matched-pair study, we analyzed the association of a phenotypically relevant NQO1 polymorphism (C609T) with risk of secondary malignant neoplasms (SMN) after treatment for childhood acute lymphoblastic leukemia. Patients carrying a variant low-activity NQO1 allele had a significantly increased risk of developing a SMN. The observed effect was restricted to solid tumors.
Key words: acute lymphoblastic leukemia, childhood, secondary malignant neoplasms, NQO1, polymorphism.
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |